Feng Wu

机构：China Tobacco Guangxi Industrial (China), The First People's Hospital of Wenling · ORCID：0000-0003-4714-7707

发表论文 76 篇 · 总被引 1829 次 · h-index 21

代表论文

• Surface-modified bacteria: synthesis, functionalization and biomedical applications (2023 · Chemical Society Reviews · 被引 131)
• Biointerface mineralization generates ultraresistant gut microbes as oral biotherapeutics (2023 · Science Advances · 被引 102)
• Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable nanocoating (2023 · Materials Today · 被引 99)
• Nanomaterial-based ophthalmic drug delivery (2023 · Advanced Drug Delivery Reviews · 被引 75)
• Triggerable Prodrug Nanocoating Enables On-Demand Activation of Microbial and Small-Molecular Therapeutics for Combination Treatment (2023 · Journal of the American Chemical Society · 被引 62)
• Generating dual structurally and functionally skin-mimicking hydrogels by crosslinking cell-membrane compartments (2024 · Nature Communications · 被引 43)